Literature DB >> 28794343

Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine.

Tetiana I Bogdanova1,2, Vladimir A Saenko1, Mitsuyoshi Hirokawa3, Masahiro Ito4, Liudmyla Yu Zurnadzhy2, Toshitetsu Hayashi3, Tatiana I Rogounovitch1, Akira Miyauchi3, Mykola D Tronko2, Shunichi Yamashita1.   

Abstract

This study set out to compare structural and invasive characteristics of sporadic papillary thyroid carcinoma (PTC) in age-matched groups of children and adolescents of Japan and Ukraine to provide detailed histopathological analysis of tumors from different geographical areas with different iodine intake. A total of 348 (160 Japanese and 188 Ukrainian) PTCs from patients without radiation history were analyzed initially as a combined pediatric group and then subdivided into childhood (aged ≤14 years) and adolescent (aged from 15 to ≤18 years) age series. On multivariate comparison, the Japanese pediatric PTC was characterized by a higher sex ratio (p=1.504E-4), and a higher frequency of microcarcinoma (p=0.039), papillary dominant growth pattern (p=0.024), focal oxyphilic cell metaplasia (p=7.644E-6), intrathyroid spread (p=0.010), lymphatic/vascular invasion (p=0.01) and regional lymph node metastases (p=3.540E-6). In the Ukrainian group, multifocal (p=0.004) and non-encapsulated tumors with the solid-trabecular growth pattern (p=0.05) were more frequent. Childhood Japanese PTCs differed from Ukrainian PTCs by more pronounced invasive properties such as lymphatic/vascular invasion and nodal disease, but did not differ by the dominant growth pattern. In adolescents, the differences were detected not only for lymph node metastases, but also for a higher frequency of the papillary dominant pattern in Japanese PTC. Overall, significantly higher frequencies of oxyphilic cell metaplasia and more pronounced invasive features observed in the Japanese PTC in both age-matched series represent the major differences between the tumors from two geographical areas.

Entities:  

Keywords:  Japan; Pathology; Pediatric papillary thyroid carcinoma; Sporadic thyroid cancer; Ukraine

Mesh:

Substances:

Year:  2017        PMID: 28794343     DOI: 10.1507/endocrj.EJ17-0134

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Chernobyl-related thyroid cancer.

Authors:  Sergei V Jargin
Journal:  Eur J Epidemiol       Date:  2018-04-07       Impact factor: 8.082

2.  Solid papillary thyroid carcinoma with Hashimoto's thyroiditis: description of a further case with challenging cytological features.

Authors:  Franco Fulciniti; Jessica Barizzi; Pierpaolo Trimboli; Luca Giovanella
Journal:  BMJ Case Rep       Date:  2019-01-17

3.  Histopathological analysis of papillary thyroid carcinoma detected during ultrasound screening examinations in Fukushima.

Authors:  Shinichi Suzuki; Tetiana I Bogdanova; Vladimir A Saenko; Yuko Hashimoto; Masahiro Ito; Manabu Iwadate; Tatiana I Rogounovitch; Mykola D Tronko; Shunichi Yamashita
Journal:  Cancer Sci       Date:  2019-01-20       Impact factor: 6.716

4.  Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm.

Authors:  Kristen Romanelli; Justin Wells; Aneeta Patel; Maria Mendonca Torres; John Costello; Kirk Jensen; Vasyl Vasko
Journal:  Ther Adv Endocrinol Metab       Date:  2021-11-24       Impact factor: 3.565

5.  Association between excessive chronic iodine exposure and the occurrence of papillary thyroid carcinoma.

Authors:  Fengyan Huang; Wei Cong; Juan Xiao; Yong Zhou; Maosong Gong; Jingfu Sun; Liqun Shan; Qiang Xiao; Lihua Wang; Jianing Liu; Zhigang Yu; Hongying Jia
Journal:  Oncol Lett       Date:  2020-09-03       Impact factor: 2.967

Review 6.  Pediatric Thyroid Cancer in Europe: An Overdiagnosed Condition? A Literature Review.

Authors:  Andreea-Ioana Stefan; Andra Piciu; Alexandru Mester; Dragos Apostu; Marius Badan; Claudiu-Iulian Badulescu
Journal:  Diagnostics (Basel)       Date:  2020-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.